Former Division Chief Dr. Deininger on the Cover of "Blood"

Originally Published On: February 16, 2022

The research of our former Division Chief, Dr. Mike Deininger was featured on the cover and article content of the journal Blood. The work done at the University of Utah showed that suppression in the expression of the MS4A3 membrane protein contributes to the progression of chronic myeloid leukemia (CML) and resistance to the BCR-ABL inhibitor imatinib. Congratulations to the Deininger research group.